About Us
Investor Relations
Corporate Profile
Calendar
Presentations
Press Releases
Corporate Governance
Management
Board of Directors
Committee Composition
Contact the Board
Insider Transactions
Financial Information
SEC Filings
Financial Reports
Quarterly Results
Key Ratios
Stock Information
Historic Stock Lookup
Investment Calculator
Dividend History
Analyst Coverage
Ownership Profile
Investor FAQs
Contact Us
Email Alerts
Newsroom
Marketed Products
ARCALYST
®
(rilonacept)
Clinical Pipeline
Aflibercept (VEGF Trap)
VEGF Trap - Eye
Rilonacept (IL-1 Trap)
Research Focus Areas
Angiogenesis
Oncology
Ophthalmology
Cardiovascular Diseases
Immunity and Inflammation
Infectious Diseases
Metabolic Diseases and Obesity
Muscle Disorders
Pain
Bone Disease
Research Publications
Technology Platforms
VelociGene
®
VelociMouse
®
VelocImmune
®
Antibodies
Traps
Protein Production
VelociMab™
Industrial Capabilities
Careers
Contact Us
Site Map
SEARCH
Events & Presentations
Details on this event are not available.
Back to previous page
Print page
Email page
Stock Information
NASDAQ:REGN
$24.60
+ 0.18
Sep 9, 2010
4:00 PM ET
Quotes delay at least 20min., by eSignal.
3 Mo.
6 Mo.
1 Yr.
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
REGN Snapshot
RSS News Feeds
Search Investor Relations
Investor site
Section only
Featured Report
2009
Annual Report and 10K
2010
Proxy Statement
2010 1st Quarter 10-Q
2008
Annual Report